Weber to lead Cancer
Weber was named the new director of the U.Va.
Cancer Center last month. He is currently a professor of microbiology
and the Weaver Professor of Oncology at U.Va.
are very pleased that Michael Weber has agreed to lead the University
of Virginia Cancer Center. He is one of the nation's most outstanding
cancer researchers. Our shared goal is to take the Cancer Center
to the top five in the United States, and he is just the person
to get us there," said Dr. Robert M. Carey, dean of the School
former director, Dr. Charles E. "Snuffy" Myers Jr.,
stepped down to pursue research toward a cure for prostate cancer,
which he was diagnosed with in February 1999. It is currently
joined the faculty in 1983. As the associate director for development
since 1987 and associate director for laboratory research since
1990, Weber has already had significant roles at the Cancer Center.
"This is an historic moment in cancer research. The knowledge
about cancer cells and genes gained over the past 10 years, combined
with the completion of the human genome project, means that for
the first time there is realistic hope that cancer can be defeated,"
Weber said. "I believe the University of Virginia Cancer
Center can play a major role in accelerating the discovery of
new knowledge and the translation of that knowledge into treatments,
diagnostics and preventives that will improve the lives of people
in Virginia and throughout the nation."
research centers on understanding how the process called signal
transduction controls cancer cell growth and development. His
lab focuses on prostate cancer and currently has four grants from
the National Institutes of Health and one from CaPCURE to support
this work. Founder of the Molecular Medicine Graduate Program,
Weber is a reviewer for several scientific publications and has
been the editor of the journal Molecular and Cellular Biology.
He chairs the Scientific Advisory Board for Argonex, a Charlottesville-based
biotechnology company, and serves on the New York-based Upstate
Biotechnology's Scientific Advisory Board.
earned a B.S. from Haverford College and a Ph.D. in cell biology
from the University of California at San Diego. He completed postdoctoral
work in tumor virology at the University of California-Berkley,
was a Dernham Postdoctoral Fellow of the American Cancer Society
and received a MERIT award from the National Cancer Institute.